A randomised, double-blind, placebo-controlled, 2-period crossover study to evaluate effects of multiple oral doses of S-555739 on nasal allergen challenge in subjects with intermittent grass pollen sensitive allergic rhinitis.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2012
At a glance
- Drugs Asapiprant (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 29 Jul 2011 New trial record